TICLOPIDINE-250 250 MG
TICLOPIDINE HYDROCHLORIDE : 250 MG · DIN 02238208 · PRO DOC LIMITEE
Health Canada status: CANCELLED POST MARKET
What is TICLOPIDINE-250?
TICLOPIDINE-250 250 MG contains TICLOPIDINE HYDROCHLORIDE : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 02238208, held by PRO DOC LIMITEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 13-Jul-2010. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is TICLOPIDINE-250 called?
The same molecule, TICLOPIDINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| THROMBOPAT | Latin | Morocco |
| TICLID | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02238208 |
|---|---|
| Brand name | TICLOPIDINE-250 |
| Generic / active ingredient | TICLOPIDINE HYDROCHLORIDE : 250 MG |
| Manufacturer | PRO DOC LIMITEE |
| Strength | 250 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | B01AC05 TICLOPIDINE |
| AHFS class | 20:12.18 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 13-Jul-2010 |
| Original market date | 1999-11-18 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02238208 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2238208 |
| Brand name | TICLOPIDINE-250 |
| Active ingredient / INN | TICLOPIDINE HYDROCHLORIDE : 250 MG |
| ATC code | B01AC05 |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B01 |
| AHFS class | 20:12.18 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | PRO DOC LIMITEE |
Which pack is which?
| Strength on the label | 250 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code B01AC05 TICLOPIDINE. 0 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALTI-TICLOPIDINE - TAB 250MG | 250 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02194422 |
| DOM-TICLOPIDINE | 250 MG | TABLET | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02243808 |
| MYLAN-TICLOPIDINE | 250 MG | TABLET | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 02239744 |
| PMS-TICLOPIDINE | 250 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02243327 |
| SANDOZ TICLOPIDINE | 250 MG | TABLET | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02243587 |
| TEVA-TICLOPIDINE | 250 MG | TABLET | TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02236848 |
| TICLID 250MG TABLETS | 250 MG | TABLET | HOFFMANN-LA ROCHE LIMITED | CANCELLED POST MARKET | DIN 02162776 |
| TICLID TAB 250MG | 250 MG | TABLET | SYNTEX INC. | CANCELLED POST MARKET | DIN 01911759 |
| TICLOPIDINE | 250 MG | TABLET | SANIS HEALTH INC | CANCELLED POST MARKET | DIN 02343045 |
| TICLOPIDINE | 250 MG | TABLET | APOTEX INC | APPROVED | DIN 02237560 |
Who else supplies TICLOPIDINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TICLOPIDINE appears in 8 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.